Sepsis

As 2019 comes to a close, the Healio Pulmonology Editors have compiled a list of the most-read articles published this year.

Healio Pulmonology has you covered on some of the year’s top news from medical meetings. We bring you highlights from the American Thoracic Society International Conference and the CHEST Annual Meeting.

Ontera and QuantuMDx announced that they will collaborate on a technology to quickly detect bloodstream infections and drug resistance, with an aim toward improving outcomes for patients with sepsis.

Shionogi won FDA approval for Fetroja for the treatment of complicated UTIs, or cUTIs, in adults with limited or no alternative treatment options.

Receiving an infectious disease consultation within 12 hours of arriving at the hospital was associated with a 40% reduced risk for in-hospital mortality among patients with sepsis, according to recently published study findings.

Adults with diabetes have increased risks for infections, such as influenza, cellulitis and sepsis, compared with adults without diabetes, according to findings published in Diabetes Care.

According to research published in JAMA, nearly one-quarter of all maternal deaths in the United States from 2013 to 2016 were related to sepsis, and more than a third of those deaths occurred after hospital discharge. Overall, maternal sepsis occurred in around 0.04% of deliveries in the U.S., the researchers reported.

Among patients with severe manifestations of sepsis, the sensitivity of blood cultures decreased after initiation of empirical antimicrobial therapy, according to a study published in the Annals of Internal Medicine.

New data published in JAMA Network Open show that PCSK9 genetic variants were not associated with the risk for sepsis or sepsis outcomes in patients hospitalized with infection.

Around two-thirds of patients in a 5-year, multisite study who survived hospitalization for sepsis demonstrated persistent elevated levels of inflammation and immunosuppression biomarkers for up to 1 year, placing them at risk for worse long-term outcomes, including death or readmission, researchers found.